← Компания

ID_KLBF 2024-06-30 H1 — report review

Status: OK; Currency: IDR; Amounts unit: millions; Forms: ✓ ✓ ✓

Дата публикации отчёта: Не сохранена для этого периода — укажите financial_report_date в строке (EDGAR filingDate, KASE change_date или manual_catalog).

Full financial report: Отчёт (PDF)

PDF (local): data/raw_pdfs/ID_KLBF/2024-06-30_H1_KLBF_Q2_2024.pdf

Чтобы заново выполнить поиск форм и превью из PDF, откройте эту ссылку Основная ссылка запускает пересчёт в фоне: панель статуса, затем готовая страница. Тяжёлый режим с refresh по умолчанию тоже в фоне (иначе прокси даёт 502). &sync=1 — только для одного долгого синхронного ответа (не рекомендуется). Можно ?refresh=1, ?recalc=1, ?nocache=1 или ?recompute=1. (дождаться в браузере: синхронное обновление)

Сопоставление метрик (значение → evidence)

Значения метрик приведены к единицам дашборда, где это применимо; в колонке evidence — сохранённый фрагмент из текстового слоя PDF или OCR на этапе извлечения.

Statement pages (discovery)

Превью страниц и восстановленные таблицы

Подсветка Жёлтая строка — совпадение с evidence; оранжевая ячейка — точное число, взятое для метрики (наведите на строку). Выручка Опер. прибыль Аморт. и износ EBITDA Чистая прибыль cash debt_short debt_long Активы Капитал Операц. ДДС Инвест. ДДС

Зелёная / янтарная / красная полоса у подписи строки — итог/субитог, где сумма детальных строк сравнивается с числом в отчёте (эвристика). Под каждой таблицей — список проверок (Σ строк vs отчёт, статус).

P&L

P&L — PDF page 5

No Camelot table — OCR (v8) below.

GPU v8 OCR — page 5 (34 rows). Blank amount cells are normal for section headers and line-wrapped captions; 0 from OCR on those rows is not a reported financial zero. Amounts follow the PDF header (often thousands of currency).

#	Joined label	Column 2	Column 3	Column 4
0	The original consolidated financial statements included herein are in
1	the Indonesian language.
2	PT KALBE FARMA Tbk DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk AND ITS SUBSIDIARIES
3	LAPORAN POSISI KEUANGAN KONSOLIDASIAN CONSOLIDATED STATEMENT
4	Tanggal 30 Juni 2024 (Belum Diaudit) OF FINANCIAL POSITION
5	(Disajikan dalam Rupiah, kecuali dinyatakan lain) As of June 30, 2024 (Unaudited)
6	(Expressed in Rupiah, unless otherwise stated)
7	ASET
8	ASET LANCAR
9	Kas dan setara kas	3692521306308	2.4	3232420596769
10	Piutang usaha	0	2.3
11	Pihak ketiga, neto	5344695145637	0	4600108623230
12	Pihak berelasi	43603093897	8	51862073259
13	Piutang lain-lain	0	2.6
14	Pihak ketiga	266763117185	0	155021066866
15	Pihak berelasi	24266881533	8000000000	13149147203
16	Aset keuangan lancar lainnya	155110082846	2.7	165496270442
17	Persediaan neto	6370011629019	2.3	6791979793011
18	Pajak pertambahan nilai
19	dibayar di muka	593496654876	2.3	465509623490
20	Biaya dibayar di muka	66736436961	10	37371816832
21	Aset lancar lainnya	314199085054	11	404805089758
22	Total Aset Lancar	16871403433316	0	15917724100860
23	ASET TIDAK LANCAR
24	Aset keuangan tidak lancar lainnya	310913231233	2.12	321056181886
25	Investasi pada entitas asosiasi	143855043954	2.3	129742418236
26	Aset pajak tangguhan, neto	132681395027	2.3	136102644092
27	Tagihan restitusi pajak	119432890362	2.3	128669562280
28	Aset tetap, neto	8074863353503	2.3	7978027474025
29	Aset takberwujud, neto	2220243344728	2.3	1778032069582
30	Aset hak-guna neto	95805137533	2.3	89013773105
31	Aset tidak lancar lainnya	596442677858	2.3	579199958257
32	Total Aset Tidak Lancar	11694237074198	0	11139844081463
33	TOTAL ASET	28565640507514	0	27057568182323

P&L — PDF page 6

No Camelot table — OCR (v8) below.

GPU v8 OCR — page 6 (40 rows). Blank amount cells are normal for section headers and line-wrapped captions; 0 from OCR on those rows is not a reported financial zero. Amounts follow the PDF header (often thousands of currency).

#	Joined label	Column 2	Column 3	Column 4
0	The original consolidated financial statements included herein are in
1	the Indonesian language.
2	PT KALBE FARMA Tbk: DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk AND ITS SUBSIDIARIES
3	LAPORAN POSISI KEUANGAN KONSOLIDASIAN CONSOLIDATED STATEMENT
4	(lanjutan) OF FINANCIAL POSITION (continued)
5	Tanggal 30 Juni 2024 (Belum Diaudit) As of June 30, 2024 (Unaudited)
6	(Disajikan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
7	LIABILITAS
8	LIABILITAS JANGKA PENDEK
9	Utang bank jangka pendek	560200000000	2.18	120800000000
10	Utang usaha	0	2.2
11	Pihak ketiga	1892.124	0	1584837372868
12	Pihak berelasi	138870136135	8	105882232758
13	Utang lain-lain	0	2.21
14	Pihak ketiga	692557215491	0	547972415828
15	Pihak berelasi	2330262491	8	255875577
16	Beban akrual	546873732338	2.22	369115840662
17	Liabilitas imbalan kerja
18	jangka pendek	83664224228	2	109425250214
19	Utang pajak	259234245694	2.3	225196597099
20	Bagian jangka pendek dari:
21	Utang bank	63860864940	2.18	157493959061
22	Liabilitas sewa	15299597959	2.3	21465468538
23	Utang pembiayaan	723532320	2	723532320
24	Total Liabilitas Jangka Pendek	4255738458261	0	3243168544925
25	LIABILITAS JANGKA PANJANG
26	Pinjaman jangka panjang;
27	setelah dikurangi dengan
28	bagian jangka pendek:
29	Utang bank	224057486996	2.18	298336872439
30	Liabilitas sewa	20449668710	2.3	20442051140
31	Utang pembiayaan	967835568	2	2365264318
32	Utang obligasi	131368000000	2.19
33	Liabilitas pajak tangguhan, neto	47741986964	2.3	35789992933
34	Liabilitas imbalan kerja
35	jangka panjang	343863448737	2.3	336943622353
36	Utang lain-lain jangka panjang
37	Pihak berelasi	499824000	2.8	499824000
38	Total Liabilitas Jangka Panjang	769948250975	0	694377627183
39	TOTAL LIABILITAS	5025686709236	0	3937546172108

BS

BS — PDF page 7

Camelot table (pages 7, primary page 7).

#	Joined label	Line item	Column 2	Column 3	Equity Attributable to → Owners o…
0	Diatribusikan kepada Equity Attributable to	Diatribusikan kepada			Equity Attributable to
1	Pemilik Entitas Induk Owners of the Parent Company	Pemilik Entitas Induk			Owners of the Parent Company
2	Modal saham - nilai nominal Share capital - Rp10 par value	Modal saham - nilai nominal			Share capital - Rp10 par value
3	Rp10 per saham per share	Rp10 per saham			per share
4	Modal dasar - Authorized -	Modal dasar -			Authorized -
5	85.000.000.000 saham 85,000,000,000 shares	85.000.000.000 saham			85,000,000,000 shares
6	Modal ditempatkan dan disetor Issued and fully paid -	Modal ditempatkan dan disetor			Issued and fully paid -
7	penuh - 46.875.122.110 saham 468.751.221.100 24 468.751.221.100 46,875,122,110 shares	penuh - 46.875.122.110 saham	468.751.221.100	24	468.751.221.100 46,875,122,110 shares
8	Tambahan modal disetor, neto (33.093.373.814) 2,25 (34.118.673.814) Additional paid-in capital, net	Tambahan modal disetor, neto	(33.093.373.814)	2,25	(34.118.673.814) Additional paid-in capital, net
9	Selisih transaksi dengan Differences arising from transaction	Selisih transaksi dengan			Differences arising from transaction
10	kepentingan non-pengendali 377.187.510.852 2,26 377.208.986.365 with non-controlling interests	kepentingan non-pengendali	377.187.510.852	2,26	377.208.986.365 with non-controlling interests
11	Saldo laba Retained earnings	Saldo laba			Retained earnings
12	Telah ditentukan penggunaannya 371.687.456.205 24 344.019.975.805 Appropriated	Telah ditentukan penggunaannya	371.687.456.205	24	344.019.975.805 Appropriated
13	Belum ditentukan penggunaannya 21.506.250.550.639 24 21.162.752.455.815 Unappropriated	Belum ditentukan penggunaannya	21.506.250.550.639	24 21.162.752.455.815	Unappropriated
14	Saham treasuri - Treasury stock -	Saham treasuri -			Treasury stock -
15	631.912.800 saham pada 631,912,800 shares as of	631.912.800 saham pada			631,912,800 shares as of
16	30 Juni 2024 dan 619.480.700 June 30, 2024 and 619,480,700	30 Juni 2024 dan 619.480.700			June 30, 2024 and 619,480,700
17	saham pada 31 Desember 2023 (1.024.271.987.000) 2,24 (1.003.973.113.000) shares as of December 31, 2023	saham pada 31 Desember 2023	(1.024.271.987.000)	2,24	(1.003.973.113.000) shares as of December 31, 2023
18	Penghasilan komprehensif lain Other comprehensive income	Penghasilan komprehensif lain			Other comprehensive income
19	Selisih kurs atas penjabaran Differences arising from foreign	Selisih kurs atas penjabaran			Differences arising from foreign
20	laporan keuangan 86.644.300.454 2 40.083.774.764 currency translation	laporan keuangan	86.644.300.454	2	40.083.774.764 currency translation
21	Laba belum direalisasi Unrealized gain on	Laba belum direalisasi			Unrealized gain on
22	dari aset keuangan tersedia available-for-sale	dari aset keuangan tersedia			available-for-sale

No subtotal/total rows matched the built-in patterns on this table (or fewer than two detail lines above each candidate).

BS — PDF page 8

Camelot table (pages 8, primary page 8).

#	Joined label	Line item	2024	Period Ended June 30 → Catatan/	2023	NET SALES → COST OF GOODS SOLD
0	Period Ended June 30			Period Ended June 30
1	Catatan/			Catatan/
2	2024 Notes 2023*)		2024	Notes	2023*)
3	PENJUALAN NETO 16.328.251.670.616 2,8,28,29 15.178.929.358.642 NET SALES	PENJUALAN NETO	16.328.251.670.616	2,8,28,29	15.178.929.358.642	NET SALES
4	BEBAN POKOK PENJUALAN (9.863.753.850.034) 2,8,28,30 (9.005.909.066.487) COST OF GOODS SOLD	BEBAN POKOK PENJUALAN	(9.863.753.850.034)	2,8,28,30	(9.005.909.066.487)	COST OF GOODS SOLD
5	LABA BRUTO 6.464.497.820.582 6.173.020.292.155 GROSS PROFIT	LABA BRUTO	6.464.497.820.582		6.173.020.292.155	GROSS PROFIT
6	Beban penjualan (3.224.530.506.160) 2,28,31 (3.203.934.485.409) Selling expenses	Beban penjualan	(3.224.530.506.160)	2,28,31	(3.203.934.485.409)	Selling expenses
7	General and administrative					General and administrative
8	Beban umum dan administrasi (731.167.340.465) 2,28,32 (734.586.345.725) expenses	Beban umum dan administrasi	(731.167.340.465)	2,28,32	(734.586.345.725)	expenses
9	Beban penelitian Research and development	Beban penelitian				Research and development
10	dan pengembangan (215.615.074.478) 2,28,33 (207.074.908.976) expenses	dan pengembangan	(215.615.074.478)	2,28,33	(207.074.908.976)	expenses
11	Pendapatan operasi lainnya 48.061.529.289 2,8,28,37 34.492.534.920 Other operating income	Pendapatan operasi lainnya	48.061.529.289	2,8,28,37	34.492.534.920	Other operating income
12	Beban operasi lainnya (27.354.219.840) 2,28,36 (136.240.893.801) Other operating expenses	Beban operasi lainnya	(27.354.219.840)	2,28,36	(136.240.893.801)	Other operating expenses
13	Penghasilan bunga 75.461.668.518 2,28,35 40.526.165.908 Interest income	Penghasilan bunga	75.461.668.518	2,28,35	40.526.165.908	Interest income
14	Interest expense and					Interest expense and
15	Beban bunga dan keuangan (37.754.846.859) 2,28,34 (50.057.701.527) financial charges	Beban bunga dan keuangan	(37.754.846.859)	2,28,34	(50.057.701.527)	financial charges
16	Bagian atas laba Share in gain of the	Bagian atas laba				Share in gain of the
17	entitas asosiasi, neto 15.832.518.116 2,13,23,28 23.266.885.675 associates, net	entitas asosiasi, neto	15.832.518.116	2,13,23,28	23.266.885.675	associates, net
18	LABA SEBELUM BEBAN INCOME BEFORE	LABA SEBELUM BEBAN				INCOME BEFORE
19	PAJAK PENGHASILAN 2.367.431.548.703 1.939.411.543.220 INCOME TAX EXPENSE	PAJAK PENGHASILAN	2.367.431.548.703		1.939.411.543.220	INCOME TAX EXPENSE
20	BEBAN PAJAK PENGHASILAN (536.619.211.522) 2,3,23,28 (422.744.166.806) INCOME TAX EXPENSE	BEBAN PAJAK PENGHASILAN	(536.619.211.522)	2,3,23,28	(422.744.166.806)	INCOME TAX EXPENSE
21	LABA PERIODE BERJALAN 1.830.812.337.181 1.516.667.376.414 INCOME FOR THE PERIOD	LABA PERIODE BERJALAN	1.830.812.337.181		1.516.667.376.414	INCOME FOR THE PERIOD
22	PENGHASILAN OTHER COMPREHENSIVE	PENGHASILAN				OTHER COMPREHENSIVE
23	KOMPREHENSIF LAIN INCOME	KOMPREHENSIF LAIN				INCOME
24	Pos-pos yang tidak akan Items that will not be	Pos-pos yang tidak akan				Items that will not be
25	direklasifikasi ke laba rugi - - reclassified to profit or loss	direklasifikasi ke laba rugi	-		-	reclassified to profit or loss
26	Pos-pos yang akan direklasifikasi Items that will be reclassified	Pos-pos yang akan direklasifikasi				Items that will be reclassified
27	ke laba rugi: to profit or loss:	ke laba rugi:				to profit or loss:

No subtotal/total rows matched the built-in patterns on this table (or fewer than two detail lines above each candidate).

CF

CF — PDF page 9

No Camelot table — OCR (v8) below.

GPU v8 OCR — page 9 (22 rows). Blank amount cells are normal for section headers and line-wrapped captions; 0 from OCR on those rows is not a reported financial zero. Amounts follow the PDF header (often thousands of currency).

#	Joined label	Column 2	Column 3	Column 4
0	The original consolidated financial statements included herein are in
1	the Indonesian language.
2	PT KALBE FARMA Tbk: DAN ENTITAS ANAKNYA PT KALBE FARMA Tbk AND ITS SUBSIDIARIES
3	LAPORAN LABA RUGI DAN PENGHASILAN CONSOLIDATED STATEMENT OF PROFIT OR LOSS
4	KOMPREHENSIF LAIN KONSOLIDASIAN (lanjutan) AND OTHER COMPREHENSIVE INCOME
5	Untuk Periode yang berakhir pada Tanggal (continued)
6	30 Juni 2024 (Belum Diaudit) For the Period Ended June 30, 2024 (Unaudited)
7	(Disajikan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
8	Laba (Rugi) Periode Berjalan Yang
9	Dapat Diatribusikan Kepada:
10	Pemilik entitas induk	1805095883934	2.28	1528997185878
11	Kepentingan non-pengendali	25716453247	2.28	-12329809464
12	Total	1830812337181	0	1516667376414
13	Total Laba (Rugi) Komprehensif
14	Periode Berjalan Yang Dapat
15	Diatribusikan Kepada:
16	Pemilik entitas induk	0.838	0	1481850959268
17	Kepentingan non-pengendali	25716453247	2.28	-12329809464
18	Total	1863795441744	0	1469521149804
19	Laba per Saham Dasar
20	Yang Dapat Diatribusikan
21	kepada Pemilik Entitas Induk	38.93	2.24	32.87

Formulas used

• Net debt: debt_short + debt_long + other_financial_liabilities + non_controlling_interest − cash (mln); [DeepSeek] net_debt (mln IDR, batch apply)
• EBITDA: operating_profit + da (mln)